A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

Smith+Nephew Announces 1st Robotic-assisted Surgery Using its LEGION CONCELOC Cementless Total Knee System

9Smith+Nephew (LSE: SN), (NYSE: SNN), the global medical technology company, today announces the first robotic-assisted surgery using its LEGION CONCELOC Cementless Total Knee System was performed by Dr. Cyna Khalily, an orthopaedic surgeon specializing in adult reconstructive surgery of the hip and knee in Louisville, KY.

Smith+Nephew is the only medical device company to offer both total and partial cementless knee implants, and now, a robotic-assisted solution for cementless total knee arthroplasty (TKA) with the CORI Surgical System. The LEGION CONCELOC Cementless Total Knee System addresses the critical elements of the cementless total knee through its unique design. The asymmetrical keel is designed to provide immediate rotational stability, while the patented 3D printed structure of CONCELOC Advanced Porous Titanium encourages biological ingrowth.

The CORI Surgical System is a second-generation platform that is small, portable, and capable of performing robotic-assisted knee and computer-guided hip surgery on a single platform. Unlike other systems, it eliminates time, costs, and radiation exposure1 associated with preoperative CT imaging.

“The accuracy2 of precision milling, combined with the tactile feel of the press-fit and initial stability of the CONCELOC porous structure during implantation, are going to give surgeons the confidence to perform cementless total knee procedures,” said Dr. Cyna Khalily.

Smith+Nephew continues to provide technological innovation with its robotics platform, coupled with advanced materials science and a history of successful clinical performance*3-6 with leading implants, like the LEGION CONCELOC Cementless Total Knee System.

“As an orthopaedics company focused on driving technology enabled procedures, it is important for us to continue delivering on our promises and provide customers innovative, comprehensive solutions, like our cementless knee portfolio which now includes a TKA solution enabled by CORI handheld robotics,” said Randy Kilburn, Executive Vice President & General Manager, Orthopaedic Reconstruction, Robotics and Digital for Smith+Nephew.

Smith+Nephew is uniquely positioned to accommodate a comprehensive suite of procedural needs for primary implant solutions using enabling technologies and handheld robotics.


References

  1. Ponzio DY, Lonner JH. Preoperative Mapping in Unicompartmental Knee Arthroplasty Using Computed Tomography Scans Is Associated with Radiation Exposure and Carries High Cost. J Arthroplasty. 2015;30(6):964-967
  2. Kaper BP, Villa A. Accuracy and Precision of a Handheld Robotic-guided Distal Femoral Osteotomy in Robotic-assisted Total Knee Arthroplasty. European Knee Society Arthroplasty Conference;2019; Valencia, Spain.
  3. Victor J, Ghijselings S, Tajdar F, et al. Total knee arthroplasty at 15-17 years: does implant design affect outcome? Int Orthop. 2014;38(2):235-241.
  4. Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR) 2021. Hip, Knee & Shoulder Arthroplasty Annual Report.
  5. National Joint Registry for England, Wales, Northern Ireland and the Isle of Man. Hertfordshire, UK 2021. 18th Annual Report.
  6. McCalden RW, Hart GP, MacDonald SJ, Naudie DD, Howard JH, Bourne RB. Clinical Results and Survivorship of the GENESIS II Total Knee Arthroplasty at a Minimum of 15 Years. J Arthroplasty. 2017;32(7):2161-2166
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy